These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 33213829)

  • 1. Therapeutic modalities and novel approaches in regenerative medicine for COVID-19.
    Ramezankhani R; Solhi R; Memarnejadian A; Nami F; Hashemian SMR; Tricot T; Vosough M; Verfaillie C
    Int J Antimicrob Agents; 2020 Dec; 56(6):106208. PubMed ID: 33213829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics.
    Kumar S; Çalışkan DM; Janowski J; Faist A; Conrad BCG; Lange J; Ludwig S; Brunotte L
    Front Immunol; 2021; 12():752227. PubMed ID: 34659259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
    Bilal M; Iqbal HMN
    Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
    Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
    Front Immunol; 2020; 11():569760. PubMed ID: 33362758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.
    Shahverdi M; Darvish M
    Curr Mol Med; 2021; 21(7):562-572. PubMed ID: 33272178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
    Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
    Front Immunol; 2021; 12():658519. PubMed ID: 34276652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: The status and perspectives in delivery points of view.
    Chung JY; Thone MN; Kwon YJ
    Adv Drug Deliv Rev; 2021 Mar; 170():1-25. PubMed ID: 33359141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
    Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K
    Int Rev Immunol; 2021; 40(1-2):54-71. PubMed ID: 33111578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Repurposed Therapeutics and New Vaccines against COVID-19 and Their Clinical Status.
    Banday AH; Shameem SA; Ajaz SJ
    SLAS Discov; 2020 Dec; 25(10):1097-1107. PubMed ID: 32692266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Research on Coronavirus: Pathogenic Mechanisms, Antiviral Drugs, and New Vaccines.
    Zhang M; Lang Y; Li W
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).
    Beeraka NM; Tulimilli SV; Karnik M; Sadhu SP; Pragada RR; Aliev G; Madhunapantula SV
    Biomed Res Int; 2021; 2021():8160860. PubMed ID: 34159203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief review on repurposed drugs and vaccines for possible treatment of COVID-19.
    De P; Chakraborty I; Karna B; Mazumder N
    Eur J Pharmacol; 2021 May; 898():173977. PubMed ID: 33639193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective.
    Perazzolo S; Zhu L; Lin W; Nguyen A; Ho RJY
    J Pharm Sci; 2021 Mar; 110(3):1002-1017. PubMed ID: 33248057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: A review of therapeutic strategies and vaccine candidates.
    Izda V; Jeffries MA; Sawalha AH
    Clin Immunol; 2021 Jan; 222():108634. PubMed ID: 33217545
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.